Your browser doesn't support javascript.
loading
Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
Kim, Hyunju; Wang, Dan; Chalmers, John; Jun, Min; Zoungas, Sophia; Marre, Michel; Hamet, Pavel; Harrap, Stephen; Mancia, Giuseppe; Poulter, Neil R; Cooper, Mark E; Woodward, Mark; Selvin, Elizabeth; Rebholz, Casey M.
Afiliación
  • Kim H; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Wang D; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
  • Chalmers J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Jun M; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA.
  • Zoungas S; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Marre M; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Hamet P; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Harrap S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Mancia G; Department of Diabetology, Endocrinology, and Nutrition, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.
  • Poulter NR; Department of Medicine, Centre Hospitalier de I'Universite de Montreal (CHUM) | CHUM, Montreal, Québec, Canada.
  • Cooper ME; The University of Melbourne and Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Woodward M; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
  • Selvin E; The International Centre for Circulatory Health, Imperial College, London, UK.
  • Rebholz CM; Diabetes Department, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
J Diabetes ; 12(12): 929-941, 2020 Dec.
Article en En | MEDLINE | ID: mdl-32609422
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders / 6_kidney_renal_pelvis_ureter_cancer Asunto principal: Enfermedades Vasculares / Biomarcadores / Diabetes Mellitus Tipo 2 / Tasa de Filtración Glomerular Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_diabetes / 6_endocrine_disorders / 6_kidney_renal_pelvis_ureter_cancer Asunto principal: Enfermedades Vasculares / Biomarcadores / Diabetes Mellitus Tipo 2 / Tasa de Filtración Glomerular Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos